CA1123337A - Compositions pharmaceutiques antimitotiques - Google Patents

Compositions pharmaceutiques antimitotiques

Info

Publication number
CA1123337A
CA1123337A CA374,650A CA374650A CA1123337A CA 1123337 A CA1123337 A CA 1123337A CA 374650 A CA374650 A CA 374650A CA 1123337 A CA1123337 A CA 1123337A
Authority
CA
Canada
Prior art keywords
pregna
hexaene
methyl
triol
acetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA374,650A
Other languages
English (en)
Inventor
Richard W. Draper
Charles J. Casmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD International Holdings GmbH
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA000307894A external-priority patent/CA1118410A/fr
Application filed by Scherico Ltd filed Critical Scherico Ltd
Priority to CA374,650A priority Critical patent/CA1123337A/fr
Application granted granted Critical
Publication of CA1123337A publication Critical patent/CA1123337A/fr
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA374,650A 1977-07-26 1981-04-03 Compositions pharmaceutiques antimitotiques Expired CA1123337A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA374,650A CA1123337A (fr) 1977-07-26 1981-04-03 Compositions pharmaceutiques antimitotiques

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81918277A 1977-07-26 1977-07-26
US819,182 1977-07-26
CA000307894A CA1118410A (fr) 1977-07-26 1978-07-21 19-nor-pregnahexenes, methode de preparation, et compositions pharmaceutiques qui en renferment
CA374,650A CA1123337A (fr) 1977-07-26 1981-04-03 Compositions pharmaceutiques antimitotiques

Publications (1)

Publication Number Publication Date
CA1123337A true CA1123337A (fr) 1982-05-11

Family

ID=27165763

Family Applications (1)

Application Number Title Priority Date Filing Date
CA374,650A Expired CA1123337A (fr) 1977-07-26 1981-04-03 Compositions pharmaceutiques antimitotiques

Country Status (1)

Country Link
CA (1) CA1123337A (fr)

Similar Documents

Publication Publication Date Title
US4172132A (en) 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
US4124707A (en) 7α-Halogeno-3,20-dioxo-1,4-pregnadienes, methods for their manufacture, their use as anti-inflammatory agents, and pharmaceutical formulations useful therefor
US4472393A (en) 3,20-Dioxo-1,4-pregnadiene-17α-ol 17-aromatic heterocycle carboxylates
US4267173A (en) Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
US4607028A (en) Novel carboxylic acid esters
US4910192A (en) Topically active steroidal anti-inflammatory agents
US4336200A (en) 17α-Acyloxy-5β-corticoids
US4576936A (en) 6α-Fluoro-9α-chloro-prednisolone 17,21-diesters
US4318853A (en) 9β,11β-Epoxy-5β-corticoids
US3984544A (en) Retinoic acid esters of steroids of the pregnane series, their use in the treatment of acne and pharmaceutical formulations useful therefor
US4201778A (en) 6-Acyloxy-1,4,6-pregnatrienes, their use as anti-inflammatory agents, methods for their manufacture, and 6-oxo-1,4-pregnadiene intermediates
US4024131A (en) 16-Methyl-9α-halo steroid esters, ethers and preparation thereof
GB1563638A (en) 21-halogenopregnane compounds
US4427671A (en) Steroids esterified in position 17 and thioesterified in position 21, a process for preparing them and their use as medicaments
CA1123337A (fr) Compositions pharmaceutiques antimitotiques
US4185101A (en) 1,3,5(10),6,8-19-Nor-pregnapentaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
CA1118410A (fr) 19-nor-pregnahexenes, methode de preparation, et compositions pharmaceutiques qui en renferment
US4427591A (en) Reduced A ring-Δ9(11) -corticoids
US4207316A (en) Novel 17-substituted 11 β-hydroxy steroids of the pregnane series, their manufacture, preparation and use
GB1594852A (en) Derivatives of 9-chloroprednisolone
US3763196A (en) 17-esters of 6alpha-9alpha-difluoro-21-desoxyprednisolone
KR840000154B1 (ko) 신규 6α-플루오로-프레드니솔론 17, 21-디에스테르의 제조방법
IE43926B1 (en) 11,12-unsaturated-9-fluoro-steroids and a process for their manufacture
JPS6361000B2 (fr)
GB1589585A (en) 12a-halocorticoids

Legal Events

Date Code Title Description
MKEX Expiry